Applied Biosystems to Webcast Presentations at Investor Conferences Scheduled for the Weeks of September 4 and 11.

FOSTER CITY, Calif. -- Presenting September 7 at the Thomas Weisel Partners Healthcare Conference and September 12 at the Bear Stearns Healthcare Conference

Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, will webcast its presentations at two upcoming financial conferences.

Applied Biosystems will webcast its presentation at the Thomas Weisel Partners Healthcare Conference on Thursday, September 7, 2006. The live webcast is scheduled to begin at 2:05 p.m. ET. Kevin P. Corcoran, Vice President and General Manager, Genetic Analysis Business Unit, Molecular and Cell Biology Division, will provide a brief opening statement and be interviewed, together with Dennis L. Winger, Chief Financial Officer for Applera Corporation, by a Thomas Weisel research analyst.

Applied Biosystems will also webcast its presentation at the Bear Stearns Annual Healthcare Conference on Tuesday, September 12, 2006. The live webcast is scheduled to begin at 3:30 p.m. ET. Tony L. White, Chief Executive Officer of Applera Corporation, will provide a brief overview of the business and be interviewed by a Bear Stearns research analyst.

Interested parties may access the live webcasts and replays by visiting the Investors & Media section of either the Applied Biosystems web site at http://ir.appliedbiosystems.com or the Applera web site at www.applera.com. It is suggested that interested parties access the webcasts 15 minutes before the start of the live webcast. The webcast replays will be archived on the Presentations page of the Investors section of each website.

About Applera Corporation and Applied Biosystems

Applera Corporation consists of two operating groups. The Applied Biosystems Group serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific discoveries and develop new pharmaceuticals. Applied Biosystems' products also serve the needs of some markets outside of life science research, which we refer to as "applied markets," such as the fields of: human identity testing (forensic and paternity testing); biosecurity, which refers to products needed in response to the threat of biological terrorism and other malicious, accidental, and natural biological dangers; and quality and safety testing, for example in food and the environment. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.9 billion during fiscal 2006. The Celera Genomics Group is primarily a molecular diagnostics business that is using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers, and is developing diagnostic products based on these markers as well as other known markers. Celera Genomics maintains a strategic alliance with Abbott for the development and commercialization of molecular, or nucleic acid-based, diagnostic products, and it is also developing new diagnostic products outside of this alliance. Through its genomics and proteomics research efforts, Celera Genomics is also discovering and validating therapeutic targets, and it is seeking strategic partnerships to develop therapeutic products based on these discovered targets. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.applera.com, or by telephoning 800.762.6923. Information about Applied Biosystems is available at http://www.appliedbiosystems.com.

Copyright(C) 2006. Applera Corporation. All Rights Reserved. Applied Biosystems, AB (Design), and Celera are registered trademarks, and Applera and Celera Genomics are trademarks of Applera Corporation or its subsidiaries in the U.S. and/or certain other countries.